The Remarkable Growth of CAR T-Cell Therapy: Forecasts Reach $27.5 Billion by 2033#United_States#Chicago#CAR_T-cell_Therapy#Immunotherapy_Innovations#Hematologic_Cancers
The Remarkable Growth of CAR T-Cell Therapy: Forecasts Reach $27.5 Billion by 2033
The CAR T-cell therapy market is expected to skyrocket from $2.7 billion in 2025 to over $27.5 billion by 2033, fueled by innovations and increasing adoption rates.
third-news.com
March 26, 2025 at 2:12 PM
Everybody can reply
Significant Growth Projections for the CAR T-cell Therapy Market from 2025 to 2034#United_States#Las_Vegas#Cancer_Treatment#CAR_T-cell_Therapy#Miltenyi_Biomedicine
Significant Growth Projections for the CAR T-cell Therapy Market from 2025 to 2034
The CAR T-cell therapy market is set for substantial growth between 2025 and 2034, driven by research investments and innovative therapies targeting various cancers.
third-news.com
October 28, 2025 at 9:43 PM
Everybody can reply
New LLS Docuseries Unveils Breakthroughs in CAR T-cell Therapy for Blood Cancer#United_States#Washington#CAR_T-cell_Therapy#Blood_Cancer#LLS
New LLS Docuseries Unveils Breakthroughs in CAR T-cell Therapy for Blood Cancer
The Leukemia & Lymphoma Society's new docuseries aims to empower blood cancer patients with knowledge about CAR T-cell therapy, featuring inspiring patient stories.
third-news.com
March 4, 2025 at 1:38 PM
Everybody can reply
1 likes
Pioneers of CAR T-Cell Therapy Honored with 2025 Merkin Prize#United_States#Cambridge#CAR_T-cell_Therapy#Broad_Institute#Merkin_Prize
Pioneers of CAR T-Cell Therapy Honored with 2025 Merkin Prize
Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain are recognized for their groundbreaking work on CAR T-cell therapy, advancing cancer treatment.
third-news.com
October 31, 2025 at 6:05 PM
Everybody can reply
Porton Advanced and EVA Pharma Collaborate to Enhance CAR T-Cell Therapy Access in MEA Region#CAR_T-cell_Therapy#Egypt#Cairo#Porton_Advanced#EVA_Pharma
Porton Advanced and EVA Pharma Collaborate to Enhance CAR T-Cell Therapy Access in MEA Region
Porton Advanced Solutions and EVA Pharma have signed an MOU to enhance access to CAR T-cell therapies in the Middle East and Africa, boosting local manufacturing and technology transfer.
third-news.com
June 26, 2025 at 1:55 PM
Everybody can reply
Innovators Awarded 2025 Merkin Prize for CAR T-cell Breakthroughs in Cancer Treatment#USA#Cambridge#CAR_T-cell_Therapy#Richard_N._Merkin_Prize#biomedical_innovation
Innovators Awarded 2025 Merkin Prize for CAR T-cell Breakthroughs in Cancer Treatment
The 2025 Merkin Prize honors pioneers of CAR T-cell therapy, recognizing their life-saving contributions to personalized cancer treatment.
third-news.com
May 21, 2025 at 4:33 PM
Everybody can reply
Tampa General Hospital Launches Innovative Outpatient Cell Therapy Unit for Cancer Treatment#United_States#Tampa#CAR_T-cell_Therapy#Tampa_General#Cancer_Institute
Tampa General Hospital Launches Innovative Outpatient Cell Therapy Unit for Cancer Treatment
Tampa General Hospital has introduced a new outpatient Cellular-Immunotherapy Transplant Unit aimed at improving cancer treatment for patients. This initiative enables patients to receive care in a more comfortable home environment.
third-news.com
December 12, 2024 at 3:52 PM
Everybody can reply
The Emily Whitehead Foundation Broadens Its Mission to Support All Cancer and Rare Disease Patients#United_States#cancer_support#CAR_T-cell_Therapy#Philipsburg#Emily_Whitehead_Foundation
The Emily Whitehead Foundation Broadens Its Mission to Support All Cancer and Rare Disease Patients
The Emily Whitehead Foundation has announced a major shift in its mission, now supporting all cancer and rare disease patients while advocating for access to advanced therapies and research.
third-news.com
September 30, 2025 at 6:39 PM
Everybody can reply
CARsgen's Satri-cel: A Breakthrough in CAR T-Cell Therapy for Cancer#China#Shanghai#CAR_T-cell_Therapy#Satri-cel#CARsgen_Therapeutics
CARsgen's Satri-cel: A Breakthrough in CAR T-Cell Therapy for Cancer
CARsgen Therapeutics reveals significant findings on satricabtagene autoleucel, or 'satri-cel', presented at key global medical venues, highlighting efficacy in advanced cancer treatments.
third-news.com
June 2, 2025 at 12:24 AM
Everybody can reply
Kyverna Therapeutics CEO to Highlight Advancements at Jefferies Global Healthcare Conference#United_States#New_York#CAR_T-cell_Therapy#Kyverna_Therapeutics#KYV-101
Kyverna Therapeutics CEO to Highlight Advancements at Jefferies Global Healthcare Conference
Kyverna Therapeutics will showcase its cell therapy advancements, including innovative CAR T-cell treatments, during the upcoming Jefferies Global Healthcare Conference.
third-news.com
May 28, 2025 at 8:13 PM
Everybody can reply
Addressing Issues in Accessing CAR T-Cell Therapy for Patients#USA#CAR_T-cell_Therapy#Florida_Cancer_Specialists#Fort_Myers#Lucio_Gordan
Addressing Issues in Accessing CAR T-Cell Therapy for Patients
Dr. Lucio Gordan sheds light on barriers to CAR T-cell therapy accessibility at the Mayo Clinic's 34th Annual Review. Challenges include costs and structural gaps.
third-news.com
August 4, 2025 at 2:34 PM
Everybody can reply
The Promising Landscape of Follicular Lymphoma Therapies: Advances and Key Players#None#Immunotherapy#Follicular_Lymphoma#CAR_T-cell_Therapy
The Promising Landscape of Follicular Lymphoma Therapies: Advances and Key Players
Explore the robust clinical pipeline for follicular lymphoma treatments, showcasing 50+ companies and innovative therapies in development.
third-news.com
November 28, 2024 at 10:35 PM
Everybody can reply